Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
about
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Lack of association between gene sequence variations of platelet membrane receptors and aspirin responsiveness detected by the PFA-100 system in patients with coronary artery diseasePlatelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO studyGene sequence variations of the platelet P2Y12 receptor are associated with coronary artery diseaseThe P2Y 13 Met-158-Thr polymorphism, which is in linkage disequilibrium with the P2Y 12 locus, is not associated with acute myocardial infarction.Associations between P2RY12 gene polymorphisms and risks of clopidogrel resistance and adverse cardiovascular events after PCI in patients with acute coronary syndrome.A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty.Clopidogrel "resistance": where are we now?Personalized approaches to clopidogrel therapy: are we there yet?Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery diseasePharmacogenomics of platelet responsiveness to aspirin.Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease.Endobiogeny: a global approach to systems biology (part 1 of 2).Pharmacogenetics of cardiovascular drug therapy.P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use.Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivityClopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations.Does i-T744C P2Y12 Polymorphism Modulate Clopidogrel Response among Moroccan Acute Coronary Syndromes Patients?Genetic causes of clopidogrel nonresponsiveness: which ones really count?Factors associated with clopidogrel nonresponsiveness.Pharmacogenetics guided anticoagulation.Prasugrel resistance: fact or fiction.The pharmacogenetics of antiplatelet agents: towards personalized therapy?Pharmacogenetics and pharmacogenomics of thienopyridines: clinically relevant?Variability of clopidogrel response in patients with type 2 diabetes mellitus.Recent advances in the pharmacogenetics of clopidogrel.Genetic determinants of response to cardiovascular drugs.Genetic and non-genetic factors affecting the response to clopidogrel therapy.Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor.Efficacy of clopidogrel treatment and platelet responsiveness in peripheral arterial procedures.Molecular defects of the platelet P2 receptors.Clinical pharmacokinetics and pharmacodynamics of clopidogrel.Genetically Determined Platelet Reactivity and Related Clinical Implications.Effects of testosterone and 17β-oestradiol on expression of the G protein-coupled receptor P2Y12 in megakaryocytic DAMI cells.A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.Frequency of single nucleotide platelet receptor gene polymorphism (P2Y12-i744T>C) in coronary artery disease patients among Tamilian population.Relationship between clopidogrel-related polymorphisms and variable platelet reactivity at 1 year: A cohort study from Han Chinese.Stroke and aspirin non-responder patients: relation with hypertension and platelet response to adenosine diphosphate.Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms.
P2860
Q26801867-BEDFFFFA-8A40-467C-B51B-262504A5416DQ28211198-2B2967AD-D5AF-432B-82CE-73101FA8AC1EQ28218790-350F6042-DD33-4B7B-A720-1906F658755DQ28221103-458507D1-7682-4715-AFB7-7FB6C412BFC1Q33316014-211CE8A0-98D5-4D65-994B-826762B8628CQ33621348-458C339D-1C56-4F3B-83E7-E37B51907CDAQ34150640-1073773B-03E3-4AB8-AE77-0A8549E63DA3Q34212563-83A8D7B9-BE64-4BDE-9252-5153AA20583BQ34460548-B084A6A6-9832-4AE0-917C-6659D654819BQ34536091-DA91D432-CCA8-4720-B127-9821864BD5F9Q36536498-893E926E-1E02-4AB6-84DD-1C8B3E8CAE85Q36989841-5C4B2758-FDF3-43D6-9E3C-EE38BBF4F0C8Q37259929-97B14ABC-BB9F-45CD-9A34-06261DD43C61Q37324095-08C2F7B8-C510-42EA-9D5A-47D87CFF354CQ37430401-B7430BFD-137E-48EF-8390-256D3EF9441BQ37562606-B6DEAC90-FD19-4784-AB85-F7631633EBB4Q37602843-6D7FA013-26E0-4CCB-B152-684204C51F38Q37627874-6539E877-8F8F-487F-ADB7-6EE3DC125362Q37651530-73C9DD7C-B0AB-4D71-977C-AE6E6F65F056Q37697779-96C37B87-B731-49FB-8AFE-76BFB014BA1DQ37709405-33C15AEF-23D1-402E-B9B6-3CB058C616ACQ37808224-7946729E-15E2-432B-AF51-632B15B1929AQ37905028-E1F85336-E590-45D2-8AB3-EB42784B7C36Q37913976-6029F514-CC41-42A8-9DF2-09100DE70A26Q37924323-3F0E6A2F-33A9-4A66-9F3E-351CF703DD08Q37936014-3099D23C-D1D3-463A-85C7-A4083D36AA3FQ37972231-EEC0475B-D439-43E6-842F-6C232F415069Q37989811-A7E05421-B0BD-44BA-9201-86FEC42412A0Q37991382-A69F5B1C-1060-439F-9190-CA33C093B045Q38001453-5F388EAF-186F-4475-94EB-B97D71319C51Q38243854-E33E0606-DDD0-4403-B489-06BDEB87F112Q38306690-3DC2E441-1EDD-465D-8990-A5064913A639Q38307535-00D8009B-1827-4AC4-A43A-CA9CC5722BBAQ38489014-BB732671-69B0-49E7-A00B-5B8F55E1F903Q39322667-0B479CA8-1352-42FA-9F99-7B4141A4BB62Q40329955-DF93EBE1-CFF3-4084-ACBA-16292ECB5048Q42193725-12DFB39B-82AD-44A3-A9A4-E8A166B10D8BQ42319053-E1F12FBC-F4A8-4198-A5FB-B7DCB792D5E2Q43255962-80FE7035-C4B8-4B86-8042-00FA2890D1FBQ45190284-B9C89424-F537-4C4C-A7D4-1D94922B58FF
P2860
Lack of association between the P2Y12 receptor gene polymorphism and platelet response to clopidogrel in patients with coronary artery disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Lack of association between th ...... with coronary artery disease.
@ast
Lack of association between th ...... with coronary artery disease.
@en
Lack of association between th ...... with coronary artery disease.
@nl
type
label
Lack of association between th ...... with coronary artery disease.
@ast
Lack of association between th ...... with coronary artery disease.
@en
Lack of association between th ...... with coronary artery disease.
@nl
prefLabel
Lack of association between th ...... with coronary artery disease.
@ast
Lack of association between th ...... with coronary artery disease.
@en
Lack of association between th ...... with coronary artery disease.
@nl
P2093
P1433
P1476
Lack of association between th ...... with coronary artery disease.
@en
P2093
Antonio Fernandez-Ortiz
Camino Bañuelos
Carlos Macaya
Celia Ramírez
Dominick J Angiolillo
Elisabetta Trabetti
Esther Bernardo
Fernando Alfonso
Javier Escaned
Manel Sabaté
P304
P356
10.1016/J.THROMRES.2005.03.001
P577
2005-04-20T00:00:00Z